USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ANTIOP, INC.
Address:
3732 Wembley Lane
LEXINGTON, KY 40515-
Phone:
N/A
URL:
N/A
EIN:
127016071
DUNS:
831025338
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $239,908.00 1
STTR Phase II $4,206,273.00 2

Award List:

Intranasal Naloxone: An Opioid Overdose Antidote

Award Year / Program / Phase:
2010 / STTR / Phase I
Award Amount:
$239,908.00
Agency:
HHS
Principal Investigator:
Daniel P. Wermeling – 859-323-7499
Research Institution:
University Of Kentucky
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): There is a significant unmet medical need to provide additional pharmacologic treatments for treatment and prevention of opioid overdose. This Fast Track STTR project proposes to apply drug delivery technologies to develop a novel use for a nasally delivered… More

Intranasal Naloxone: An Opioid Overdose Antidote

Award Year / Program / Phase:
2011 / STTR / Phase II
Award Amount:
$1,219,884.00
Agency:
HHS
Principal Investigator:
Daniel P. Wermeling – (859) 221-4138
Research Institution:
UNIVERSITY OF KENTUCKY
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): There is a significant unmet medical need to provide additional pharmacologic treatments for treatment and prevention of opioid overdose. This Fast Track STTR project proposes to apply drug delivery technologies to develop a novel use for a nasally delivered… More

Naloxone Nasal Spray Development

Award Year / Program / Phase:
2013 / STTR / Phase II
Award Amount:
$2,986,389.00
Agency:
HHS
Principal Investigator:
Daniel P. Wermeling – 859-323-7499
Research Institution:
UNIVERSITY OF KENTUCKY
RI Contact:
Abstract:
DESCRIPTION: The following proposal is a follow-on Phase 2 b application from our initial proposal (1-R42 DA 030001). U.S. drug overdose deaths, mostly commonly from opioids, now exceed deaths from automobile accidents. There is a significant unmet medical need to provide additional pharmacologic… More